Targeted Pharmacy Care Drives Star Ratings & Improves Health Outcomes

On December 9th, Mosaic Pharmacy Service presented a session at the 2021 Medicare Star Ratings & Quality Assurance Summit on the role that high-value pharmacy services can play in improving health plans’ pharmacy quality ratings, while also improving the pharmacy experience for medically complex members. Listen to our 20-minute session hosted by Patricia Powers, PharmD, BCPS, Clinical Director of Mosaic Pharmacy Service, as she discusses how the combination of population health analytics and high-value pharmacy services can enable value-based care that reduces medical utilization, drives pharmacy quality performance, and improves member experience:

Interested in learning how we can help your most complex and vulnerable health plan members? Contact us today for a risk-free assessment of your plan’s population.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.